Xin-Yu Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xin-Yu Yu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Hong Zhao
Laboratory of Neuroscience, College of Medicine, Dalian University, Dalian, People’s Republic of China
6 shared publicationsZhi-Hong Ji
Laboratory of Neuroscience, College of Medicine, Dalian University, Dalian, People’s Republic of China
6 shared publicationsChao Liu
Laboratory of Neuroscience, College of Medicine, Dalian University, Dalian, People’s Republic of China
5 shared publicationsC. Liu
Laboratory of Neuroscience, College of Medicine, Dalian University, Dalian 116622, People's Republic of China
1 shared publicationH. Zhao
Laboratory of Neuroscience, College of Medicine, Dalian University, Dalian 116622, People's Republic of China
1 shared publicationQun Gao
Laboratory of Neuroscience, College of Medicine, Dalian University, Dalian 116622, People's Republic of China
1 shared publication
Latest Publications
- 17 November 2021
- Published by Springer Nature in Neurochemical Research
- Vol. 47 (3) , 762-767
Hyperhomocysteinemia Induces Rat Memory Impairment Via Injuring Hippocampal CA3 Neurons and Downregulating cAMP Response Element-Binding Protein (CREB) Phosphorylation
Accumulated evidence demonstrated that an elevated plasma homocysteine level, hyperhomocysteinemia, induced cognitive impairment in animals, elderly and the patients with neurodegenerative diseases. To date, the underlying cellular and molecular mechanisms by which hyperhomocysteinemia induces cognitive impairment has not been clearly defined. The purpose of this study was to investigate the possible cellular and molecular mechanisms behind hyperhomocysteinemia signaling in rat memory impairment. The results from this study demonstrated that hyperhomocysteinemia induced neuronal damage and loss in hippocampal CA3 region and downregulated the cAMP response element-binding protein (CREB) phosphorylation. The findings of this study provide evidence that hyperhomocysteinemia induces rat memory impairment via injuring hippocampal CA3 neurons and downregulating CREB phosphorylation.
- 17 November 2021
- Published by Springer Nature in Neurochemical Research
- Vol. 47 (3) , 762-767
Hyperhomocysteinemia Induces Rat Memory Impairment Via Injuring Hippocampal CA3 Neurons and Downregulating cAMP Response Element-Binding Protein (CREB) Phosphorylation
Accumulated evidence demonstrated that an elevated plasma homocysteine level, hyperhomocysteinemia, induced cognitive impairment in animals, elderly and the patients with neurodegenerative diseases. To date, the underlying cellular and molecular mechanisms by which hyperhomocysteinemia induces cognitive impairment has not been clearly defined. The purpose of this study was to investigate the possible cellular and molecular mechanisms behind hyperhomocysteinemia signaling in rat memory impairment. The results from this study demonstrated that hyperhomocysteinemia induced neuronal damage and loss in hippocampal CA3 region and downregulated the cAMP response element-binding protein (CREB) phosphorylation. The findings of this study provide evidence that hyperhomocysteinemia induces rat memory impairment via injuring hippocampal CA3 neurons and downregulating CREB phosphorylation.
- 5 February 2020
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 31 (3) , 245-250
In-vitro neuroprotective effect and mechanism of 2β-hydroxy-δ-cadinol against amyloid β-induced neuronal apoptosis
Amyloid beta (Aβ) neurotoxicity plays a causative role in the pathogenesis of Alzheimer’s disease. Accumulating evidence demonstrates that Aβ neurotoxicity is mediated by glutamate excitotoxicity. In our previous study, a sesquiterpenoid compound 2β-hydroxy-δ-cadinol (HOC) which exhibited antiglutamate excitotoxicity effect was isolated from the fruits of Alpinia oxyphylla Miquel. Based on the antiglutamate excitotoxicity effect of HOC, in this study, we investigated the potential benefit of HOC in preventing Aβ(1–42)-induced neuronal apoptosis in cultured rat hippocampal neurons. The neuroprotective effect of HOC against Aβ(1–42)-induced neuronal apoptosis was assessed by Hoechst 33258 staining, reactive oxygen species (ROS) production, caspase-3 activation and caspase-3 activity. Results demonstrated that HOC treatment significantly prevented Aβ(1–42)-induced neuronal apoptosis. The underlying molecular mechanisms of HOC in preventing Aβ(1–42)-induced neuronal apoptosis may be via inhibiting Aβ(1–42)-induced ROS production, attenuating Aβ(1–42)-induced caspase-3 activation and inhibiting caspase-3 activity. This study suggests that HOC may be a potential agent for the prevention of Aβ neurotoxicity.
- 5 February 2020
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 31 (3) , 245-250
In-vitro neuroprotective effect and mechanism of 2β-hydroxy-δ-cadinol against amyloid β-induced neuronal apoptosis
Amyloid beta (Aβ) neurotoxicity plays a causative role in the pathogenesis of Alzheimer’s disease. Accumulating evidence demonstrates that Aβ neurotoxicity is mediated by glutamate excitotoxicity. In our previous study, a sesquiterpenoid compound 2β-hydroxy-δ-cadinol (HOC) which exhibited antiglutamate excitotoxicity effect was isolated from the fruits of Alpinia oxyphylla Miquel. Based on the antiglutamate excitotoxicity effect of HOC, in this study, we investigated the potential benefit of HOC in preventing Aβ(1–42)-induced neuronal apoptosis in cultured rat hippocampal neurons. The neuroprotective effect of HOC against Aβ(1–42)-induced neuronal apoptosis was assessed by Hoechst 33258 staining, reactive oxygen species (ROS) production, caspase-3 activation and caspase-3 activity. Results demonstrated that HOC treatment significantly prevented Aβ(1–42)-induced neuronal apoptosis. The underlying molecular mechanisms of HOC in preventing Aβ(1–42)-induced neuronal apoptosis may be via inhibiting Aβ(1–42)-induced ROS production, attenuating Aβ(1–42)-induced caspase-3 activation and inhibiting caspase-3 activity. This study suggests that HOC may be a potential agent for the prevention of Aβ neurotoxicity.
- 1 April 2015
- Published by Elsevier in Neuroscience
- Vol. 290, 485-491
Neuroprotection and mechanisms of atractylenolide III in preventing learning and memory impairment induced by chronic high-dose homocysteine administration in rats
- 1 April 2015
- Published by Elsevier in Neuroscience
- Vol. 290, 485-491
Neuroprotection and mechanisms of atractylenolide III in preventing learning and memory impairment induced by chronic high-dose homocysteine administration in rats
- 18 February 2015
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 56 (4) , 808-814
Neuroprotective Mechanisms of 9-Hydroxy Epinootkatol Against Glutamate-Induced Neuronal Apoptosis in Primary Neuron Culture
Glutamate-induced neuronal apoptosis has been implicated in the pathogenesis of neurological disorders. 9-Hydroxy epinootkatol (9OHEN), a sesquiterpene compound with neuroprotective activity against glutamate-induced neuronal apoptosis, was isolated from Alpinia oxyphylla Miquel in our previous study. In this study, we investigated the neuroprotective mechanisms of 9OHEN against glutamate-induced neuronal apoptosis in primary cultured neurons. The results from this study demonstrated that 9OHEN protected cortical neurons from glutamate-induced neuronal apoptosis via inhibiting glutamate-induced activation of caspase-3, inhibiting glutamate-induced reactive oxygen species (ROS) production, inhibiting glutamate-induced nitric oxide (NO) production, and downregulating glutamate-induced neuronal nitric oxide synthase (nNOS) expression. This study suggest that 9OHEN might have therapeutic potential in treating glutamate-mediated neurological diseases.
- 18 February 2015
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 56 (4) , 808-814
Neuroprotective Mechanisms of 9-Hydroxy Epinootkatol Against Glutamate-Induced Neuronal Apoptosis in Primary Neuron Culture
Glutamate-induced neuronal apoptosis has been implicated in the pathogenesis of neurological disorders. 9-Hydroxy epinootkatol (9OHEN), a sesquiterpene compound with neuroprotective activity against glutamate-induced neuronal apoptosis, was isolated from Alpinia oxyphylla Miquel in our previous study. In this study, we investigated the neuroprotective mechanisms of 9OHEN against glutamate-induced neuronal apoptosis in primary cultured neurons. The results from this study demonstrated that 9OHEN protected cortical neurons from glutamate-induced neuronal apoptosis via inhibiting glutamate-induced activation of caspase-3, inhibiting glutamate-induced reactive oxygen species (ROS) production, inhibiting glutamate-induced nitric oxide (NO) production, and downregulating glutamate-induced neuronal nitric oxide synthase (nNOS) expression. This study suggest that 9OHEN might have therapeutic potential in treating glutamate-mediated neurological diseases.
- 31 August 2014
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 55 (3) , 678-683
Neuroprotective Effect of Biatractylenolide Against Memory Impairment in d-Galactose-induced Aging Mice
Biatractylenolide, a sesquiterpene lactone, which exerted the neuroprotective effect against glutamate-induced excitotoxicity, was isolated from Atractylodis macrocephala in our previous study. In this study, we evaluated the neuroprotective effect of biatractylenolide against d-galactose-induced memory impairment and explored the potential mechanism of its action. The results showed that administration of biatractylenolide could significantly improve behavioral performance of d-galactose-treated mice in passive avoidance test and spatial learning-memory test. Administration of biatractylenolide could significantly decrease the formation of reactive oxygen species (ROS), decrease the activity of acetylcholinesterase (AChE), and increase the expression of synapsin I and protein kinase C (PKC) in d-galactose-treated mice. Our findings provide first evidence for the neuroprotective effect of biatractylenolide against d-galactose-induced memory impairment. The potential mechanisms underlying the neuroprotective effect of biatractylenolide in d-galactose-treated mice might be (i) attenuating oxidative damage via decreasing ROS formation, (ii) restoring cholinergic neurotransmission via decreasing AChE activity, and (iii) increasing the expression of memory-related proteins (synapsin I and PKC). Biatractylenolide may have therapeutic potential in aging-related memory impairment.
- 31 August 2014
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 55 (3) , 678-683
Neuroprotective Effect of Biatractylenolide Against Memory Impairment in d-Galactose-induced Aging Mice
Biatractylenolide, a sesquiterpene lactone, which exerted the neuroprotective effect against glutamate-induced excitotoxicity, was isolated from Atractylodis macrocephala in our previous study. In this study, we evaluated the neuroprotective effect of biatractylenolide against d-galactose-induced memory impairment and explored the potential mechanism of its action. The results showed that administration of biatractylenolide could significantly improve behavioral performance of d-galactose-treated mice in passive avoidance test and spatial learning-memory test. Administration of biatractylenolide could significantly decrease the formation of reactive oxygen species (ROS), decrease the activity of acetylcholinesterase (AChE), and increase the expression of synapsin I and protein kinase C (PKC) in d-galactose-treated mice. Our findings provide first evidence for the neuroprotective effect of biatractylenolide against d-galactose-induced memory impairment. The potential mechanisms underlying the neuroprotective effect of biatractylenolide in d-galactose-treated mice might be (i) attenuating oxidative damage via decreasing ROS formation, (ii) restoring cholinergic neurotransmission via decreasing AChE activity, and (iii) increasing the expression of memory-related proteins (synapsin I and PKC). Biatractylenolide may have therapeutic potential in aging-related memory impairment.
- 24 June 2014
- Published by Springer Nature in Neurochemical Research
- Vol. 39 (9) , 1753-1758
Neuroprotection of Atractylenolide III from Atractylodis macrocephalae Against Glutamate-Induced Neuronal Apoptosis Via Inhibiting Caspase Signaling Pathway
Glutamate-induced excitotoxicity appears to play a crucial role in neurological disorders. Neuroprotection against glutamate-induced excitotoxicity has been proposed as a therapeutic strategy for preventing and/or treating these excitotoxicity-mediated diseases. In the present study, atractylenolide III, which exhibited significantly neuroprotective effect against glutamate-induced neuronal apoptosis, was isolated from Atractylodes macrocephala by means of bioactivity-guided fractionation. The inhibitory effect of atractylenolide III on glutamate-induced neuronal apoptosis was in a concentration-dependent manner. The anti-apoptotic property of atractylenolide III might be mediated, in part, via inhibiting caspase signaling pathway. Atractylenolide III may have therapeutic potential in excitotoxicity-mediated neurological diseases.
- 24 June 2014
- Published by Springer Nature in Neurochemical Research
- Vol. 39 (9) , 1753-1758
Neuroprotection of Atractylenolide III from Atractylodis macrocephalae Against Glutamate-Induced Neuronal Apoptosis Via Inhibiting Caspase Signaling Pathway
Glutamate-induced excitotoxicity appears to play a crucial role in neurological disorders. Neuroprotection against glutamate-induced excitotoxicity has been proposed as a therapeutic strategy for preventing and/or treating these excitotoxicity-mediated diseases. In the present study, atractylenolide III, which exhibited significantly neuroprotective effect against glutamate-induced neuronal apoptosis, was isolated from Atractylodes macrocephala by means of bioactivity-guided fractionation. The inhibitory effect of atractylenolide III on glutamate-induced neuronal apoptosis was in a concentration-dependent manner. The anti-apoptotic property of atractylenolide III might be mediated, in part, via inhibiting caspase signaling pathway. Atractylenolide III may have therapeutic potential in excitotoxicity-mediated neurological diseases.
- 23 September 2011
- Published by Wiley in Phytotherapy Research
- Vol. 26 (4) , 557-561
Neuroprotective Effect of Rhizoma Atractylodis Macrocephalae Against Excitotoxicity‐induced Apoptosis in Cultured Cerebral Cortical Neurons
Excitotoxicity has been implicated in neurological disorders. This study investigated the neuroprotective effect of the extract from Rhizoma Atractylodis macrocephalae on excitotoxicity‐induced neuronal apoptosis in primary cultured cerebral cortical neurons. Excitotoxicity was induced by exposure of cortical neurons to glutamate. Neuronal apoptosis and the protective effect of Rhizoma Atractylodis macrocephalae extract were examined by multi‐indices including cell viability assay, morphological features, DNA fragmentation and flow cytometric analysis. After exposure of cultured neurons to glutamate for 24 h, the neurons exhibited marked apoptotic‐like death. Co‐treatment of the neurons with glutamate and Rhizoma Atractylodis macrocephalae extract significantly elevated the cell viability, and reduced the number of apoptotic cells. These results demonstrate that Rhizoma Atractylodis macrocephalae is an effective neuroprotective agent against glutamate‐induced excitotoxicity and may have therapeutic potential in excitotoxicity‐mediated diseases. Copyright © 2011 John Wiley & Sons, Ltd.
- 23 September 2011
- Published by Wiley in Phytotherapy Research
- Vol. 26 (4) , 557-561
Neuroprotective Effect of Rhizoma Atractylodis Macrocephalae Against Excitotoxicity‐induced Apoptosis in Cultured Cerebral Cortical Neurons
Excitotoxicity has been implicated in neurological disorders. This study investigated the neuroprotective effect of the extract from Rhizoma Atractylodis macrocephalae on excitotoxicity‐induced neuronal apoptosis in primary cultured cerebral cortical neurons. Excitotoxicity was induced by exposure of cortical neurons to glutamate. Neuronal apoptosis and the protective effect of Rhizoma Atractylodis macrocephalae extract were examined by multi‐indices including cell viability assay, morphological features, DNA fragmentation and flow cytometric analysis. After exposure of cultured neurons to glutamate for 24 h, the neurons exhibited marked apoptotic‐like death. Co‐treatment of the neurons with glutamate and Rhizoma Atractylodis macrocephalae extract significantly elevated the cell viability, and reduced the number of apoptotic cells. These results demonstrate that Rhizoma Atractylodis macrocephalae is an effective neuroprotective agent against glutamate‐induced excitotoxicity and may have therapeutic potential in excitotoxicity‐mediated diseases. Copyright © 2011 John Wiley & Sons, Ltd.